Stockreport

Immuno-Oncology Investments Accelerate as Pipeline Catalysts Multiply in 2026 [Globe and Mail, The (Toronto, Canada)]

Oncolytics Biotech Inc. - Common Shares  (ONCY) 
Last oncolytics biotech inc. - common shares earnings: 11/12 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.oncolyticsbiotech.com
PDF is forecast to grow from $65.22 billion in 2025 to $170.19 billion by 2032, fueled by checkpoint inhibitors, CAR-T cell therapy, and cancer vaccines [1] . Five companies [Read more]